Table 1.
Demographical data of the patients as well as comorbidities and ongoing treatments (ADHD, Attention Deficit Hyperactivity Disorder; SAD, Social Anxiety Disorder; ODD, Oppositional Defiant Disorder; CBT, Cognitive-Behavioral Therapy).
| PATIENT | AGE | GENDER | COMORBIDITIES | MEDICATION | OTHER TREATMENTS |
|---|---|---|---|---|---|
| 1 | 9 | M | ADHD | Omega-3; Melatonin; Probiotics; Phosphatidylserine | CBT; Speech therapy |
| 2 | 5 | M | ADHD; SAD | Melatonin; Probiotics; Phosphatidylserine | CBT; Parent Training |
| 3 | 7 | F | ODD | Probiotics | CBT; Speech Therapy |
| 4 | 6 | F | SAD | Omega-3 | CBT |
| 5 | 12 | M | ADHD | Omega-3; Probiotics; Phosphatidylserine | CBT; Speech Therapy |
| 6 | 7 | F | ADHD | Melatonin; Phosphatidylserine | CBT; Speech Therapy |
| 7 | 15 | M | Omega-3; Melatonin; Probiotics | CBT; Speech Therapy | |
| 8 | 14 | M | SAD | Melatonin | CBT; Speech Therapy |
| 9 | 7 | M | ODD | CBT; Speech Therapy; Parent Training | |
| 10 | 7 | M | ODD; SAD | Omega-3; Melatonin; Probiotics | |
| 11 | 8 | M | Melatonin | ||
| 12 | 5 | F | SAD | CBT; Speech Therapy | |
| 13 | 8 | F | ODD | Omega-3 | CBT |
| 14 | 8 | M | ADHD | Phosphatidylserine | CBT; Speech Therapy |
| 15 | 10 | M | ADHD | Probiotics; Phosphatidylserine | |
| 16 | 11 | F | ADHD; SAD | Omega-3; Phosphatidylserine | CBT; Speech Therapy |
| 17 | 7 | F | ADHD | Omega-3; Melatonin; Probiotics; Phosphatidylserine | CBT; Speech Therapy |
| 18 | 7 | M | Omega-3; Melatonin | CBT; Speech Therapy; Parent Training | |
| 19 | 14 | F | ADHD; SAD | Omega-3; Probiotics; Phosphatidylserine | CBT; Speech Therapy |
| 20 | 14 | M | CBT; Speech Therapy | ||
| 21 | 10 | M | ADHD | Melatonin; Phosphatidylserine | CBT; Speech Therapy |